BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17684154)

  • 21. CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.
    Hayat A; O'Brien D; O'Rourke P; McGuckin S; Fitzgerald T; Conneally E; Browne PV; McCann SR; Lawler MP; Vandenberghe E
    Leuk Lymphoma; 2006 Nov; 47(11):2371-9. PubMed ID: 17107912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
    Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
    Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
    Rampazzo E; Bonaldi L; Trentin L; Visco C; Keppel S; Giunco S; Frezzato F; Facco M; Novella E; Giaretta I; Del Bianco P; Semenzato G; De Rossi A
    Haematologica; 2012 Jan; 97(1):56-63. PubMed ID: 21933855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
    Abo Elwafa R; Abd Elrahman A; Ghallab O
    Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PD-1/PD-L1 expression and its implications in patients with chronic lymphocytic leukemia].
    Li JH; Pang NN; Zhang ZH; Zhang R; Chen G; Qu JH
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):198-203. PubMed ID: 28395442
    [No Abstract]   [Full Text] [Related]  

  • 26. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
    Del Principe MI; Del Poeta G; Buccisano F; Maurillo L; Venditti A; Zucchetto A; Marini R; Niscola P; Consalvo MA; Mazzone C; Ottaviani L; Panetta P; Bruno A; Bomben R; Suppo G; Degan M; Gattei V; de Fabritiis P; Cantonetti M; Lo Coco F; Del Principe D; Amadori S
    Blood; 2006 Aug; 108(3):853-61. PubMed ID: 16601244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CD38 ectoenzyme family: advances in basic science and clinical practice.
    Morabito F; Damle RN; Deaglio S; Keating M; Ferrarini M; Chiorazzi N
    Mol Med; 2006; 12(11-12):342-4. PubMed ID: 17380202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Tian T; Li L; Qiu HX
    Leuk Res; 2009 Feb; 33(2):237-43. PubMed ID: 18674817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.
    Tonino SH; Spijker R; Luijks DM; van Oers MH; Kater AP
    Blood; 2008 Aug; 112(3):840-3. PubMed ID: 18519815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
    Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
    Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD38 and chronic lymphocytic leukemia: a decade later.
    Malavasi F; Deaglio S; Damle R; Cutrona G; Ferrarini M; Chiorazzi N
    Blood; 2011 Sep; 118(13):3470-8. PubMed ID: 21765022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
    Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
    Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
    Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
    BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of laboratory tests in B-CLL patients in different clinical stages.
    Rusak M; Osada J; Pawlus J; Chociej-Stypułkowska J; Dąbrowska M; Kłoczko J
    Int J Hematol; 2011 Jun; 93(6):736-744. PubMed ID: 21626106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.
    Pittner BT; Shanafelt TD; Kay NE; Jelinek DF
    Leukemia; 2005 Dec; 19(12):2264-72. PubMed ID: 16208411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia.
    Brezinova J; Berkova A; Vcelikova S; Zemanova Z; Izakova S; Sarova I; Cechova H; Tajtlova J; Grosova L; Lizcova L; Malinova E; Zemanova M; Cmunt E; Karban J; Trneny M; Schwarz J; Michalova K
    Neoplasma; 2010; 57(3):215-21. PubMed ID: 20353271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia.
    Manocha S; Matrai Z; Osthoff M; Carter A; Pettitt AR
    Leuk Lymphoma; 2003 May; 44(5):797-800. PubMed ID: 12802916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic significance of new biological markers in chronic lymphocytic leukaemia].
    Leković D; Mihaljević B; Kraguljac-Kurtović N; Perunčić-Jovanović M; Bogdanović A; Čolović M; Gotić M
    Srp Arh Celok Lek; 2011; 139(11-12):753-8. PubMed ID: 22338471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.